Does NITRENDIPINE Cause Hyperparathyroidism secondary? 26 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Hyperparathyroidism secondary have been filed in association with NITRENDIPINE. This represents 7.4% of all adverse event reports for NITRENDIPINE.
26
Reports of Hyperparathyroidism secondary with NITRENDIPINE
7.4%
of all NITRENDIPINE reports
0
Deaths
26
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From NITRENDIPINE?
Of the 26 reports, 26 (100.0%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NITRENDIPINE. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does NITRENDIPINE Cause?
Dizziness (83)
Syncope (55)
Fall (54)
Drug ineffective (49)
Bradycardia (48)
Oedema peripheral (44)
Hypertension (42)
Presyncope (41)
Atrial fibrillation (37)
Benign prostatic hyperplasia (36)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
Which NITRENDIPINE Alternatives Have Lower Hyperparathyroidism secondary Risk?
NITRENDIPINE vs NITRIC
NITRENDIPINE vs NITROFURANTOIN
NITRENDIPINE vs NITROFURANTOIN\NITROFURANTOIN
NITRENDIPINE vs NITROFURAZONE
NITRENDIPINE vs NITROGLYCERIN